Brandau O, Nyakatura G, Jedele K B, Platzer M, Achatz H, Ross M, Murken J, Rosenthal A, Meindl A
Abteilung für Medizinische Genetik, Kinderpoliklinik der Universität, München, Germany.
Eur J Hum Genet. 1998 Sep-Oct;6(5):459-66. doi: 10.1038/sj.ejhg.5200207.
The gene for ubiquitin hydrolase on the X chromosome (UHX1), cloned and mapped to Xp21.2-p11.2, is a candidate gene for retinal diseases. We used fine mapping techniques to localise UHX1 between markers DXS1266 and DXS337, where congenital stationary night blindness (XICSNB) and retinitis pigmentosa type 2 (RP2) are also located. Reevaluation of the UHX1 gene structure demonstrated five new exons, for a total of 21 exons and a predicted protein product of 963 amino acids. Evaluation of patients revealed no UHX1 mutations using SSCP (10 CSNB1 and 20 XLRP) or deletion screening with cDNA hybridisation (13 CSNB1 and 43 XLRP). Likewise, no aberrations were found in the nearby PCTAIRE1 (PCTK1) gene in 13 CSNB1 and 43 XLRP patients by deletion screening. Thus mutations of UHX1, and probably PCTK1, do not appear to cause common X-linked eye diseases. UHX1's role in patients with mental retardation may be appropriate for further investigations into UHX1 function.
位于X染色体上的泛素水解酶基因(UHX1)已被克隆并定位到Xp21.2 - p11.2,它是视网膜疾病的一个候选基因。我们使用精细定位技术将UHX1定位在标记DXS1266和DXS337之间,先天性静止性夜盲症(XICSNB)和2型视网膜色素变性(RP2)也位于此区域。对UHX1基因结构的重新评估发现了五个新外显子,使得外显子总数达到21个,预测的蛋白质产物为963个氨基酸。对患者的评估显示,使用单链构象多态性分析(SSCP,10例先天性静止性夜盲症1型患者和20例X连锁视网膜色素变性患者)或cDNA杂交缺失筛查(13例先天性静止性夜盲症1型患者和43例X连锁视网膜色素变性患者)均未发现UHX1突变。同样,通过缺失筛查,在13例先天性静止性夜盲症1型患者和43例X连锁视网膜色素变性患者中,附近的PCTAIRE1(PCTK1)基因也未发现异常。因此,UHX1以及可能的PCTK1突变似乎不会导致常见的X连锁眼病。UHX1在智力迟钝患者中的作用可能适合进一步研究UHX1的功能。